# Tron Inc.: financial statements, quarterly

TRON · Nasdaq · CIK 1956744 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tron.md) · [Financials](/companies/tron/financials.md) · [Filings](/companies/tron/filings.md) · [Insiders](/companies/tron/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tron/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.1](/filings/0001493152-24-045149.md) | [1.2 d](/filings/0001641172-25-001862.md) | [1.0](/filings/0001641172-25-009334.md) | [1.5](/filings/0001641172-25-022765.md) | [0.9](/filings/0001493152-25-021526.md) | [0.9 d](/filings/0001493152-26-012723.md) | [1.1](/filings/0001493152-26-021991.md) | [1.3](/filings/0001493152-26-037161.md) | [1.1](/filings/0001493152-25-021526.md) | [1.2 d](/filings/0001493152-26-012723.md) | [1.2](/filings/0001493152-26-021991.md) | [1.6](/filings/0001493152-26-037161.md) |
| Cost of revenue | $m | [0.9](/filings/0001493152-24-045149.md) | [0.9 d](/filings/0001641172-25-001862.md) | [0.8](/filings/0001641172-25-009334.md) | [1.2](/filings/0001641172-25-022765.md) | [0.7](/filings/0001493152-25-021526.md) | [0.8 d](/filings/0001493152-26-012723.md) | [0.8](/filings/0001493152-26-021991.md) | [1.1](/filings/0001493152-26-037161.md) | [0.8](/filings/0001493152-25-021526.md) | [0.9 d](/filings/0001493152-26-012723.md) | [0.9](/filings/0001493152-26-021991.md) | [1.3](/filings/0001493152-26-037161.md) |
| Gross profit | $m | [0.2](/filings/0001493152-24-045149.md) | [0.3 d](/filings/0001641172-25-001862.md) | [0.2](/filings/0001641172-25-009334.md) | [0.3](/filings/0001641172-25-022765.md) | [0.2](/filings/0001493152-25-021526.md) | [0.2 d](/filings/0001493152-26-012723.md) | [0.3](/filings/0001493152-26-021991.md) | [0.3](/filings/0001493152-26-037161.md) | [0.3](/filings/0001493152-25-021526.md) | [0.3 d](/filings/0001493152-26-012723.md) | [0.3](/filings/0001493152-26-021991.md) | [0.3](/filings/0001493152-26-037161.md) |
| Operating income | $m | not reported | not reported | not reported | [(0.5)](/filings/0001641172-25-022765.md) | [(1.1)](/filings/0001493152-25-021526.md) | [(1.0) d](/filings/0001493152-26-012723.md) | [(0.6)](/filings/0001493152-26-021991.md) | [(0.7)](/filings/0001493152-26-037161.md) | [(0.7)](/filings/0001493152-25-021526.md) | [(0.5) d](/filings/0001493152-26-012723.md) | [(0.6)](/filings/0001493152-26-021991.md) | [(0.5)](/filings/0001493152-26-037161.md) |
| Interest expense | $m | [0.0](/filings/0001493152-23-040529.md) | [0.0 d](/filings/0001493152-24-050661.md) | not reported | not reported | [0.0](/filings/0001493152-25-021526.md) | [0.0 d](/filings/0001493152-26-012723.md) | [0.0](/filings/0001493152-26-021991.md) | [0.0](/filings/0001493152-26-037161.md) | [0.0](/filings/0001493152-25-021526.md) | [0.0 d](/filings/0001493152-26-012723.md) | [0.0](/filings/0001493152-26-021991.md) | [0.0](/filings/0001493152-26-037161.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.5](/filings/0001493152-26-021991.md) | [0.8 d](/filings/0001493152-26-037161.md) |
| Net income | $m | [(1.5)](/filings/0001493152-24-045149.md) | [(0.8) d](/filings/0001641172-25-001862.md) | [(1.7)](/filings/0001493152-25-021526.md) | [(0.5)](/filings/0001493152-25-021526.md) | [(1.1)](/filings/0001493152-25-021526.md) | [(1.0) d](/filings/0001493152-26-012723.md) | [(0.6)](/filings/0001493152-26-037161.md) | [1.5](/filings/0001493152-26-037161.md) | [12.2](/filings/0001493152-25-021526.md) | [(29.8) d](/filings/0001493152-26-012723.md) | [21.6](/filings/0001493152-26-037161.md) | [2.9](/filings/0001493152-26-037161.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001493152-24-045149.md) | not reported | [(0.17)](/filings/0001641172-25-009334.md) | [(0.05)](/filings/0001641172-25-022765.md) | [(0.11)](/filings/0001493152-25-021526.md) | not reported | [(0.04)](/filings/0001493152-26-021991.md) | [0.01](/filings/0001493152-26-037161.md) | [0.04](/filings/0001493152-25-021526.md) | not reported | [0.05](/filings/0001493152-26-021991.md) | [0.01](/filings/0001493152-26-037161.md) |
| Basic EPS | $ per share | [(0.19)](/filings/0001493152-24-045149.md) | not reported | [(0.17)](/filings/0001641172-25-009334.md) | [(0.05)](/filings/0001641172-25-022765.md) | [(0.11)](/filings/0001493152-25-021526.md) | not reported | [(0.04)](/filings/0001493152-26-021991.md) | [0.07](/filings/0001493152-26-037161.md) | [0.11](/filings/0001493152-25-021526.md) | not reported | [0.08](/filings/0001493152-26-021991.md) | [0.01](/filings/0001493152-26-037161.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.3](/filings/0001493152-23-040529.md) | [3.0](/filings/0001641172-25-001862.md) | [1.8](/filings/0001493152-24-018638.md) | [1.5](/filings/0001493152-24-031263.md) | [1.0](/filings/0001493152-24-045149.md) | [1.4](/filings/0001493152-26-012723.md) | [0.9](/filings/0001641172-25-009334.md) | [5.3](/filings/0001641172-25-022765.md) | [10.6](/filings/0001493152-25-021526.md) | [10.5](/filings/0001493152-26-037161.md) | [9.9](/filings/0001493152-26-021991.md) | [9.5](/filings/0001493152-26-037161.md) |
| Current assets | $m | [4.9](/filings/0001493152-23-040529.md) | [4.5](/filings/0001641172-25-001862.md) | [3.8](/filings/0001493152-24-018638.md) | [3.3](/filings/0001493152-24-031263.md) | [2.8](/filings/0001493152-24-045149.md) | [3.5](/filings/0001493152-26-012723.md) | [3.0](/filings/0001641172-25-009334.md) | [7.3](/filings/0001641172-25-022765.md) | [12.8](/filings/0001493152-25-021526.md) | [12.4](/filings/0001493152-26-037161.md) | [26.7](/filings/0001493152-26-021991.md) | [21.6](/filings/0001493152-26-037161.md) |
| Total assets | $m | [5.0](/filings/0001493152-23-040529.md) | [4.5](/filings/0001641172-25-001862.md) | [3.8](/filings/0001493152-24-018638.md) | [3.4](/filings/0001493152-24-031263.md) | [5.7](/filings/0001493152-24-045149.md) | [6.3](/filings/0001493152-26-012723.md) | [5.8](/filings/0001641172-25-009334.md) | [112](/filings/0001641172-25-022765.md) | [245](/filings/0001493152-25-021526.md) | [211](/filings/0001493152-26-037161.md) | [253](/filings/0001493152-26-021991.md) | [256](/filings/0001493152-26-037161.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001493152-26-012723.md) | not reported | not reported | [0.8](/filings/0001493152-25-021526.md) | [0.7](/filings/0001493152-26-037161.md) | [0.9](/filings/0001493152-26-021991.md) | [0.8](/filings/0001493152-26-037161.md) |
| Total liabilities | $m | [0.5](/filings/0001493152-23-040529.md) | [0.4](/filings/0001641172-25-001862.md) | [0.4](/filings/0001493152-24-018638.md) | [0.3](/filings/0001493152-24-031263.md) | [2.5](/filings/0001493152-24-045149.md) | [1.0](/filings/0001493152-26-012723.md) | [0.8](/filings/0001641172-25-009334.md) | [0.8](/filings/0001641172-25-022765.md) | [4.8](/filings/0001493152-25-021526.md) | [1.1](/filings/0001493152-26-037161.md) | [2.8](/filings/0001493152-26-021991.md) | [3.4](/filings/0001493152-26-037161.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [4.5](/filings/0001493152-24-045149.md) | [4.1](/filings/0001493152-26-012723.md) | [3.3](/filings/0001493152-25-021526.md) | [3.1](/filings/0001493152-25-021526.md) | [3.3](/filings/0001493152-25-021526.md) | [5.3](/filings/0001493152-26-037161.md) | [5.0](/filings/0001493152-26-037161.md) | [111](/filings/0001493152-26-037161.md) | [240](/filings/0001493152-25-021526.md) | [210](/filings/0001493152-26-037161.md) | [250](/filings/0001493152-26-037161.md) | [253](/filings/0001493152-26-037161.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(872) d](/filings/0001493152-24-045149.md) | [(354) d](/filings/0001641172-25-001862.md) | [(1,170)](/filings/0001641172-25-009334.md) | [(334) d](/filings/0001641172-25-022765.md) | [(176) d](/filings/0001493152-25-021526.md) | [(1,175) d](/filings/0001493152-26-012723.md) | [(207)](/filings/0001493152-26-021991.md) | [40.9 d](/filings/0001493152-26-037161.md) | [(850) d](/filings/0001493152-25-021526.md) | [(428) d](/filings/0001493152-26-012723.md) | [(539)](/filings/0001493152-26-021991.md) | [(421) d](/filings/0001493152-26-037161.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.5](/filings/0001493152-23-040529.md) | [6.5](/filings/0001493152-24-018638.md) | [6.5](/filings/0001493152-24-031263.md) | [8.0](/filings/0001493152-24-045149.md) | [10.0](/filings/0001641172-25-009334.md) | [10.2](/filings/0001641172-25-022765.md) | [10.6](/filings/0001493152-25-021526.md) | [17.2](/filings/0001493152-26-021991.md) | [224](/filings/0001493152-26-037161.md) | [318](/filings/0001493152-25-021526.md) | [476](/filings/0001493152-26-021991.md) | [472](/filings/0001493152-26-037161.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 474,382,064 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001493152-26-037161.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.